NASDAQ:HRTX

Heron Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy HRTX

*Your capital is at risk

$0.447

-0.0032 (-0.711%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

HRTX Prediction Chart

HRTX Predictions History

Latest community submissions for HRTX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
NameNotImportant Pro	May 6, 2019	$16.55 -5.91%	$17.59	X	94.09%	0
PumpTheseNumbers Pro	May 2, 2019	$19.50 +9.24%	$17.85	X	90.76%	0
NameNotImportant Pro	May 2, 2019	$21.72 +21.68%	$17.85	X	78.32%	0
NameNotImportant Pro	Apr 22, 2019	$22.70 -1.30%	$23.00	X	98.70%	1
Bob.mullen.23865	Apr 13, 2018	$19.84 -35.16%	$30.60	X	64.80%	0
Sunny.Chyun.21972	Mar 15, 2018	$23.58 +7.67%	$21.90	X	92.30%	0
Stockdum Senior	Jul 18, 2016	$6.46 -61.59%	$16.82	X	38.40%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for HRTX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT HERON THERAPEUTICS

Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acut...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by